159 related articles for article (PubMed ID: 25868275)
21. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
22. The lncRNA MEG3/miRNA-21/P38MAPK axis inhibits coxsackievirus 3 replication in acute viral myocarditis.
He F; Liu Z; Feng M; Xiao Z; Yi X; Wu J; Liu Z; Wang G; Li L; Yao H
Virus Res; 2024 Jan; 339():199250. PubMed ID: 37865350
[TBL] [Abstract][Full Text] [Related]
23. Engineered coxsackievirus B3 containing multiple organ-specific miRNA targets showed attenuated viral tropism and protective immunity.
Xiao Z; He F; Feng M; Liu Z; Liu Z; Li S; Wang W; Yao H; Wu J
Infect Genet Evol; 2022 Sep; 103():105316. PubMed ID: 35718333
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin.
Yuan J; Zhang J; Wong BW; Si X; Wong J; Yang D; Luo H
Cell Death Differ; 2005 Aug; 12(8):1097-106. PubMed ID: 15905881
[TBL] [Abstract][Full Text] [Related]
25. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
26. Systemic analysis of a novel coxsackievirus gene delivery system in a mouse model.
Kim YJ; Yun SH; Lim BK; Park KB; Na HN; Jeong SY; Kim DS; Cho YJ; Jeon ES; Nam JH
J Microbiol Biotechnol; 2009 Mar; 19(3):307-13. PubMed ID: 19349757
[TBL] [Abstract][Full Text] [Related]
27. Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication in vitro.
Qi X; Li X; Liu M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):253-6. PubMed ID: 11498691
[TBL] [Abstract][Full Text] [Related]
28. Coxsackievirus B3 Infection of Human Neural Progenitor Cells Results in Distinct Expression Patterns of Innate Immune Genes.
Oh SJ; Gim JA; Lee JK; Park H; Shin OS
Viruses; 2020 Mar; 12(3):. PubMed ID: 32192194
[TBL] [Abstract][Full Text] [Related]
29. Baicalin Inhibits Coxsackievirus B3 Replication by Reducing Cellular Lipid Synthesis.
Wang MJ; Yang CH; Jin Y; Wan CB; Qian WH; Xing F; Li X; Liu YY
Am J Chin Med; 2020; 48(1):143-160. PubMed ID: 31903780
[TBL] [Abstract][Full Text] [Related]
30. Expression Profile and Function Analysis of Long Non-coding RNAs in the Infection of Coxsackievirus B3.
Tong L; Qiu Y; Wang H; Qu Y; Zhao Y; Lin L; Wang Y; Xu W; Zhao W; He H; Zhao G; Zhang MH; Yang D; Ge X; Zhong Z
Virol Sin; 2019 Dec; 34(6):618-630. PubMed ID: 31388922
[TBL] [Abstract][Full Text] [Related]
31. Identification of the interaction of VP1 with GM130 which may implicate in the pathogenesis of CVB3-induced acute pancreatitis.
Li X; Xia Y; Huang S; Liu F; Ying Y; Xu Q; Liu X; Jin G; Papasian CJ; Chen J; Fu M; Huang X
Sci Rep; 2015 Aug; 5():13324. PubMed ID: 26314804
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.
Yuan J; Cheung PK; Zhang HM; Chau D; Yang D
J Virol; 2005 Feb; 79(4):2151-9. PubMed ID: 15681418
[TBL] [Abstract][Full Text] [Related]
33. The Nuclear Pore Complex 62 Suppression Inhibits Coxsackievirus B Replication and Inflammatory Response.
Liu T; Shi Y; Wang H; Shen H; Qu J
Viral Immunol; 2022 Jun; 35(5):381-385. PubMed ID: 35605096
[TBL] [Abstract][Full Text] [Related]
34. Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.
Zhang QM; Song WQ; Li YJ; Qian J; Zhai AX; Wu J; Li AM; He JM; Zhao JY; Yu X; Wei LL; Zhang FM
Virol J; 2012 Dec; 9():312. PubMed ID: 23249700
[TBL] [Abstract][Full Text] [Related]
35. Rapamycin and ZSTK474 can have differential effects at different post‑infection time‑points regarding CVB3 replication and CVB3‑induced autophagy.
Chang H; Tian L; Chen J; Tang A; Li C; Li Z; Yang Z
Mol Med Rep; 2018 Jul; 18(1):1088-1094. PubMed ID: 29845290
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of CVB3-VP1 siRNA on CVB3 replication].
Chen JB; Xu CF; Yu Y; Li L; Li SJ; Chen RZ; Yang YZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):306-9. PubMed ID: 16643786
[TBL] [Abstract][Full Text] [Related]
37. Cholic Acid Attenuates ER Stress-Induced Cell Death in Coxsackievirus-B3 Infection.
Han JY; Jeong HI; Park CW; Yoon J; Ko J; Nam SJ; Lim BK
J Microbiol Biotechnol; 2018 Jan; 28(1):109-114. PubMed ID: 29032641
[TBL] [Abstract][Full Text] [Related]
38. Effect of Sophora flavescens Ait on cultured beating myocardial cells of coxsackie B3 virus infected newborn rat.
Chen S; Peng X; Liu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Jun; 14(2):137-40. PubMed ID: 11503044
[TBL] [Abstract][Full Text] [Related]
39. Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells.
Mamana J; Humber GM; Espinal ER; Seo S; Vollmuth N; Sin J; Kim BJ
Front Cell Infect Microbiol; 2023; 13():1171275. PubMed ID: 37139492
[TBL] [Abstract][Full Text] [Related]
40. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells.
Tsueng G; Tabor-Godwin JM; Gopal A; Ruller CM; Deline S; An N; Frausto RF; Milner R; Crocker SJ; Whitton JL; Feuer R
J Virol; 2011 Jun; 85(12):5718-32. PubMed ID: 21471247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
